VentriPoint Diagnostics Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VPTDF research report →
Price Chart
About the company
VentriPoint Diagnostics Ltd. is a medical technology company focused on developing and commercializing diagnostic tools worldwide. These innovative solutions are designed to monitor individuals afflicted with cardiovascular disease.
- CEO
- Hugh MacNaught
- IPO
- 2010
- Employees
- 3
- HQ
- Toronto, ON, CA
Get TickerSpark's AI analysis on VPTDF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $9.49M
- P/E
- -4.98
- PEG
- -0.06
- P/S
- 84.84
- P/B
- -3.17
- EV/EBITDA
- -8.90
- Div Yield
- 0.00%
- Gross Margin
- 89.55%
- Op Margin
- -1624.48%
- Net Margin
- -1568.50%
- ROE
- 56.40%
- ROIC
- 192.91%
Latest fiscal year · YoY change
- Revenue
- $179.78K+88.9%
- Gross Profit
- $118.59K+24.6%
- Op Income
- $-3,396,732
- Net Income
- $-3,197,633+35.0%
- EPS
- $-0.02+37.9%
- OCF Growth
- +54.1%
- FCF Growth
- +54.1%
- 52W High
- $0.14
- 52W Low
- $0.04
- 50D MA
- $0.06
- 200D MA
- $0.08
- Beta
- 0.04
- RSI (14)
- 43
- Avg Volume
- 114.03K
No earnings-call transcripts are available for VPTDF yet.
- Free Float
- 98.4%
- Shares Outstanding
- 192.88M
- Float Shares
- 189.76M
Our VPTDF coverage
Recent articles, reports, and earnings notes.
No research on VPTDF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate VPTDF report →Ventripoint Diagnostics Announces Placement of Two VMS+™ Systems for Clinical Deployment
thenewswire.com · Nov 19
Ventripoint Diagnostics Ltd. (VPT:CA) Shareholder/Analyst Call Transcript
seekingalpha.com · Oct 9
Ventripoint Provides Corporate Update and Announces Shareholder Videoconference Call
thenewswire.com · Oct 6
Ventripoint Announces Successful Completion of Annual Quality and Regulatory Audits
thenewswire.com · Sep 24
Ventripoint Closes First Tranche of Private Placement Financing and Engages Strategic Advisors to Accelerate Commercialization of VMS+™ Technology
thenewswire.com · Sep 8
UniDoc Health Signs MOU with Ventripoint Diagnostics to Evaluate Remote Cardiac Assessment and Screening Platform
accessnewswire.com · Aug 20
Ventripoint Expands Subscription Access for FDA-Cleared AI Cardiac Imaging
globenewswire.com · Aug 12
Ventripoint Diagnostics Announces Cancellation and Re-Grant of Options, Grant of Annual Incentive Options and Private Placement
thenewswire.com · Aug 7
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.